Back to Search
Start Over
Correction: Corrigendum: Long term outcome of Aldosteronism after target treatments
- Source :
- Scientific Reports. 7
- Publication Year :
- 2017
- Publisher :
- Springer Science and Business Media LLC, 2017.
-
Abstract
- Scientific Reports 6: Article number: 32103; published online: 02 September 2016; updated: 24 March 2017 The original version of this Article contained an error in the Abstract. “While need for receptor antagonist (MRA) MRA after diagnosis suggests that a defined daily dose (DDD) of MRA between 12.5and 50 mg may alleviate risk of death in a U-shape pattern”.
Details
- ISSN :
- 20452322
- Volume :
- 7
- Database :
- OpenAIRE
- Journal :
- Scientific Reports
- Accession number :
- edsair.doi...........cab634a5a6824d9e617caef97caf9b81